ES2098188A1 - Desarrollo de nanoparticulas a base de polimeros hidrofilicos. - Google Patents
Desarrollo de nanoparticulas a base de polimeros hidrofilicos.Info
- Publication number
- ES2098188A1 ES2098188A1 ES09500907A ES9500907A ES2098188A1 ES 2098188 A1 ES2098188 A1 ES 2098188A1 ES 09500907 A ES09500907 A ES 09500907A ES 9500907 A ES9500907 A ES 9500907A ES 2098188 A1 ES2098188 A1 ES 2098188A1
- Authority
- ES
- Spain
- Prior art keywords
- nanoparticles
- polymers
- hydrophilic
- development
- hydrophilic polymers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
DESARROLLO DE NANOPARTICULAS A BASE DE POLIMEROS HIDROFILICOS. LAS NANOPARTICULAS (DE TAMAÑO NANOMETRICO Y CARACTER HIDROFILICO), TAMBIEN DENOMINADAS NANOSFERAS O LATEXES, SON SISTEMAS COLOIDALES FORMADOS POR LA COMBINACION DE DOS POLIMEROS DE NATURALEZA HIDROFILICA. LOS POLIMEROS SON EL QUITOSANO (UN AMINOPOLISACARIDO) Y EL POLOXAMER (UN COPOLIMERO DEL OXIDO DE ETILENO Y DEL OXIDO DE PROPILENO). EL PROCEDIMIENTO DE OBTENCION TRANSCURRE EN FASE ACUOSA SIN NECESIDAD DE UTILIZAR DISOLVENTES ORGANICOS NI SUSTANCIAS AUXILIARES DE NATURALEZA TOXICA. LAS NANOPARTICULAS TIENEN APLICACION COMO FORMAS FARMACEUTICAS (PARA LA ADMINISTRACION IN VIVO DE INGREDIENTES ACTIVOS) DEBIDO A LA CAPACIDAD PARA RETENER EN SU INTERIOR MEDICAMENTOS Y PROTEINAS.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9500907A ES2098188B1 (es) | 1995-05-11 | 1995-05-11 | Desarrollo de nanoparticulas a base de polimeros hidrofilicos. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9500907A ES2098188B1 (es) | 1995-05-11 | 1995-05-11 | Desarrollo de nanoparticulas a base de polimeros hidrofilicos. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2098188A1 true ES2098188A1 (es) | 1997-04-16 |
ES2098188B1 ES2098188B1 (es) | 1997-12-16 |
Family
ID=8290331
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9500907A Expired - Fee Related ES2098188B1 (es) | 1995-05-11 | 1995-05-11 | Desarrollo de nanoparticulas a base de polimeros hidrofilicos. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2098188B1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112758A1 (es) * | 2003-06-20 | 2004-12-29 | Advanced In Vitro Cell Technologies, S.L. | Nanopartículas de ácido hialurónico |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2246694B1 (es) | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Nanoparticulas pegiladas. |
ES2246695B1 (es) | 2004-04-29 | 2007-05-01 | Instituto Cientifico Y Tecnologico De Navarra, S.A. | Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071644A (en) * | 1990-08-07 | 1991-12-10 | Mediventures, Inc. | Topical drug delivery with thermo-irreversible gels |
WO1996020698A2 (en) * | 1995-01-05 | 1996-07-11 | The Board Of Regents Acting For And On Behalf Of The University Of Michigan | Surface-modified nanoparticles and method of making and using same |
-
1995
- 1995-05-11 ES ES9500907A patent/ES2098188B1/es not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5071644A (en) * | 1990-08-07 | 1991-12-10 | Mediventures, Inc. | Topical drug delivery with thermo-irreversible gels |
WO1996020698A2 (en) * | 1995-01-05 | 1996-07-11 | The Board Of Regents Acting For And On Behalf Of The University Of Michigan | Surface-modified nanoparticles and method of making and using same |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004112758A1 (es) * | 2003-06-20 | 2004-12-29 | Advanced In Vitro Cell Technologies, S.L. | Nanopartículas de ácido hialurónico |
ES2226567A1 (es) * | 2003-06-20 | 2005-03-16 | Universidad De Santiago De Compostela | Nanoparticulas de acido hialuronico. |
Also Published As
Publication number | Publication date |
---|---|
ES2098188B1 (es) | 1997-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hostetler et al. | Effect of cyclodextrin on the pharmacology of antifungal oral azoles | |
EP0752245B1 (en) | Biocompatible and biodegradable nanoparticles designed for proteinaceous drugs absorption and delivery | |
DE69834025D1 (de) | Pharmazeutische zubereitungen und verfahren zu deren lokalen verabreichung | |
Lertsutthiwong et al. | Chitosan-alginate nanocapsules for encapsulation of turmeric oil | |
HUP9904174A2 (hu) | Bőrön át történő adagoláshoz szánt gyógyszerkészítmények | |
US20050037083A1 (en) | Preparation of submicron solid particle suspensions by sonication of multiphase systems | |
CA2170748A1 (en) | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis | |
CA2103447A1 (en) | Use of nano particles as pharmaceutical carriers | |
CA2180816A1 (en) | 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
CA2027592A1 (en) | Solid pharmaceutical preparations of active form of vitamin d_ of improved stability | |
CA2139133A1 (en) | Solid and liquid solutions of drugs which ar not readily soluble in water | |
CA2258811A1 (en) | Formulation for use in the prevention of pathogen induced diseases including hiv and hsv | |
ATE264666T1 (de) | Im magen verweilendes arzneimittel mit verzögerter wirkstoffabgabe | |
CA2449244A1 (en) | Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug | |
KR870006893A (ko) | 고점성 하이드로겔 또는 그 현탁액의 약학적 제제 | |
CA2233501A1 (en) | Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms | |
ATE232100T1 (de) | Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen | |
WO2004098564A3 (en) | Biodegradable nanoparticles comprising an aminoglycoside and a polymer like a polysaccharide | |
CA2041044A1 (en) | Large Intestinal Dissociative Polypeptide Series Oral Formulation | |
HUP0004173A2 (hu) | Immunszuppresszív szereket tartalmazó, helyileg alkalmazható szemgyógyászati készítmények | |
CA2212309A1 (en) | Extended-release solid oral dosage forms of drugs having low solubility in water | |
Murray et al. | Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients | |
US20070098802A1 (en) | Organic nanoparticles and associated methods | |
ES2098188A1 (es) | Desarrollo de nanoparticulas a base de polimeros hidrofilicos. | |
BR9809708A (pt) | Composições farmacêuticas de peptìdeos tendo solubilidade baixa em meio fisiológico |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19970416 Kind code of ref document: A1 Effective date: 19970416 |
|
PC2A | Transfer of patent | ||
FD2A | Announcement of lapse in spain |
Effective date: 20180806 |